These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11073133)

  • 1. Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients.
    Baum HV; Franz U; Geiss HK
    Infection; 2000 Sep; 28(5):278-81. PubMed ID: 11073133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
    Perea S; Hidalgo M; Arcediano A; Ramos MJ; Gomez C; Hornedo J; Lumbreras C; Folgueira D; Cortes-Funes H; Rodriguez-Noriega A
    J Antimicrob Chemother; 1999 Jul; 44(1):117-20. PubMed ID: 10459819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.
    Cheong HJ; Yoo CW; Sohn JW; Kim WJ; Kim MJ; Park SC
    Clin Infect Dis; 2001 Jul; 33(1):48-53. PubMed ID: 11389494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.
    Wagenlehner F; Stöwer-Hoffmann J; Schneider-Brachert W; Naber KG; Lehn N
    Int J Antimicrob Agents; 2000 Aug; 15(3):207-11. PubMed ID: 10926443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: a 6-year study of isolates from patients in England and Wales.
    Threlfall EJ; Cheasty T; Graham A; Rowe B
    Int J Antimicrob Agents; 1997 Jan; 9(3):201-5. PubMed ID: 9552717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of multi-resistant Escherichia coli.
    Guyot A; Barrett SP; Threlfall EJ; Hampton MD; Cheasty T
    J Hosp Infect; 1999 Sep; 43(1):39-48. PubMed ID: 10462638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli.
    Liss MA; Nakamura KK; Peterson EM
    J Clin Microbiol; 2013 Jan; 51(1):249-52. PubMed ID: 23152550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
    Cattaneo C; Quaresmini G; Casari S; Capucci MA; Micheletti M; Borlenghi E; Signorini L; Re A; Carosi G; Rossi G
    J Antimicrob Chemother; 2008 Mar; 61(3):721-8. PubMed ID: 18218645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
    Gupta K; Hooton TM; Stamm WE
    J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.
    Blázquez R; Menasalvas A; Carpena I; Ramírez C; Guerrero C; Moreno S
    Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):503-5. PubMed ID: 10482029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status.
    Johnson JR; Kuskowski MA; Menard M; Gajewski A; Xercavins M; Garau J
    J Infect Dis; 2006 Jul; 194(1):71-8. PubMed ID: 16741884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.